An Open, Multicenter Phase II Study to Evaluate the Safety and Efficacy of KL-A167 Injection in Relapsed or Refractory Classical Hodgkin's Lymphoma
Clinical trial NCT03580564 · COMPLETED
Trial details
- NCT number
- NCT03580564
- Sponsor
- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-01
- Primary completion
- 2020-08-22
- Enrollment
- 109
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.